These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1759358)

  • 1. [The experimental validation of associated immunization with paired combinations of vaccines].
    Gapochko KG; Vasilenko AZh; Stepanov AV; Savel'ev AP; Titova TS
    Voen Med Zh; 1991 Sep; (9):46-9. PubMed ID: 1759358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The clinico-immunological validation of associated immunization].
    Gapochko KG; Vasilenko AZh; Misnikov OP; Savel'ev AP; Stepanov AV; Titova TS
    Voen Med Zh; 1992 Mar; (3):35-8. PubMed ID: 1441243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined (associated) immunization against typhoid, typhus and plague].
    Gapochko KG; Misnikov OP; Kolkov VF; Kekcheeva NG; Semenova BN; Titova TS
    Voen Med Zh; 1994 Apr; (4):42-6, 79. PubMed ID: 8091696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination of travelers: how far have we come and where are we going?
    Chen LH; Hill DR; Wilder-Smith A
    Expert Rev Vaccines; 2011 Nov; 10(11):1609-20. PubMed ID: 22043959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of a new inactivated hepatitis A vaccine in concurrent administration with a typhoid fever vaccine or a typhoid fever + yellow fever vaccine.
    Dumas R; Forrat R; Lang J; Farinelli T; Loutan L
    Adv Ther; 1997; 14(4):160-7. PubMed ID: 10174195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
    Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M
    Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Associated live vaccine against influenza, adenovirus type 4 and Mycoplasma pneumoniae].
    Smorodintsev AA; Kolesnikov LV
    Tr Inst Im Pastera; 1982; 58():3-13. PubMed ID: 6821264
    [No Abstract]   [Full Text] [Related]  

  • 8. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus.
    Hammond SA; Raabe ML; Issel CJ; Montelaro RC
    Virology; 1999 Sep; 262(2):416-30. PubMed ID: 10502520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant vector vaccines in vaccinology.
    Hilleman MR
    Dev Biol Stand; 1994; 82():3-20. PubMed ID: 7958480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vaccinations and systemic diseases. Vaccinations and immunosuppression].
    Bouchaud O; Mouas H
    Ann Med Interne (Paris); 1998 Oct; 149(6):351-60. PubMed ID: 9853045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability of the rabbit pyrogen test and of the limulus test in predicting the pyrogenicity of vaccines in man.
    Nyerges G; Jaszovszky I
    Acta Microbiol Acad Sci Hung; 1981; 28(3):235-43. PubMed ID: 7304271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexual dimorphism of humoral immunity with human vaccines.
    Cook IF
    Vaccine; 2008 Jul; 26(29-30):3551-5. PubMed ID: 18524433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
    Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
    Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vaccination in immunodepressed patients].
    Calicó I
    Med Clin (Barc); 1991 Oct; 97(13):497-9. PubMed ID: 1758206
    [No Abstract]   [Full Text] [Related]  

  • 17. [Which vaccines for which travelers?].
    Louis FJ; Morillon M; Martet G
    Med Trop (Mars); 1997; 57(1):27-30. PubMed ID: 9289603
    [No Abstract]   [Full Text] [Related]  

  • 18. [The inhibiting effect of anticholera vaccination carried out simultaneously or at short intervals on yellow fever immunization. Is it real or assumed? Results of a retrospective study].
    Poveda JD; Raccurt CP; Le Fur R; M'Bailara L; Malvy JM; Le Bras M; Saliou P; Fleury HJ
    Bull Soc Pathol Exot; 1990; 83(4):529-35; discussion 535-6. PubMed ID: 2286006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines against bluetongue in Europe.
    Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Possibilities and limits of vaccinations].
    Schneeweiss B
    Z Arztl Fortbild (Jena); 1971 May; 65(9-10):485-95. PubMed ID: 5114862
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.